About
Dr. Pierre-Aurèle Morin is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at CHU Sherbrooke in Sherbrooke, QC, he is part of a dedicated healthcare team committed to providing comprehensive hematology (blood disorder) care. His practice adheres to the high standards set by the Collège des médecins du Québec (CMQ), ensuring quality, safety, and ethical standards in all patient interactions. Dr. Morin addresses a wide array of benign and malignant hematologic disorders, offering both diagnostic expertise and therapeutic interventions to adults with suspected or diagnosed blood conditions. Access to advanced diagnostic tools and treatment options is a key component of the care he provides, aimed at improving patient outcomes and quality of life.
He graduated with a Medical Degree in 2016 and has been practicing as a Hematologist for over 8 years, since 2016. Dr. Morin completed extensive postgraduate medical training and certification in Hematology, specializing in blood disorders, which enables him to deliver specialized, evidence-based care tailored to each patient’s needs. His ongoing commitment to professional development ensures he remains current with the latest advances in hematology and cancer care.
Driven by a philosophy of multidisciplinary, patient-centered care, Dr. Morin is dedicated to providing compassionate support while employing the most effective, evidence-based treatments. He values open communication and strives to involve patients and their families in the decision-making process. Fluent in French, he offers clear, empathetic explanations to ensure understanding and comfort throughout the treatment journey. His goal is to support the long-term health and well-being of his patients in Sherbrooke, fostering a trusting and respectful doctor-patient relationship.
Dr. Pierre-Aurèle Morin has expertise in managing a wide range of conditions, including:
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Hemolytic Anemia (e.g., Autoimmune Hemolytic Anemia - AIHA): A disorder in which red blood cells are destroyed faster than the bone marrow can produce them.
- Iron Deficiency Anemia: A common type of anemia caused by insufficient iron, leading to reduced red blood cell production and oxygen-carrying capacity.
- Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
Hematologic Malignancies (Blood Cancers) Treated
- Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): A group of chronic blood cancers where the bone marrow produces too many red blood cells, white blood cells, or platelets.
- Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
- Chronic Myeloid Leukemia (CML): A type of cancer that starts in certain blood-forming cells of the bone marrow, often managed with targeted therapies.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Pierre-Aurèle Morin or your referring physician.
- Management of Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): Treatment strategies to control blood counts, manage symptoms, and prevent complications associated with these chronic bone marrow disorders.
- Comprehensive Diagnosis & Management of Anemias: Investigating and treating various types of anemia, such as iron deficiency, vitamin B12/folate deficiency, hemolytic anemias (e.g., autoimmune hemolytic anemia), sickle cell disease, thalassemia, and aplastic anemia.
- Management of Myelodysplastic Syndromes (MDS): Diagnosis and treatment of bone marrow failure disorders, including supportive care, growth factors, and disease-modifying therapies.
- Genetic Counseling & Testing Referrals for Hereditary Cancer Syndromes: Assessment of family history and risk factors, and coordination of referrals for genetic counseling and testing for inherited predispositions to cancer (e.g., BRCA).
- Blood Product Transfusion Support & Management of Transfusion Reactions: Overseeing transfusions of red blood cells, platelets, plasma, and managing any adverse reactions.
- Iron Overload Disorders (e.g., Hereditary Hemochromatosis) Management: Monitoring and treatment, including therapeutic phlebotomy, for conditions of excess iron storage.
- Peripheral Blood Smear Review & Advanced Cytomorphology: Expert microscopic examination of blood cells to identify abnormalities and aid in diagnosis.
Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Morin provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Morin or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.
Dr. Morin practices at CHU Sherbrooke, situated in the Fleurimont West (Hospital Area) neighborhood of Sherbrooke. The hospital is easily accessible from Downtown Sherbrooke (Les Nations) and the Marché de la Gare, with public transit options provided by the Société de transport de Sherbrooke (STS). The facility is wheelchair accessible, ensuring ease of access for all patients. Paid parking options are conveniently located nearby for those arriving by car, making it straightforward to attend appointments and receive the specialized hematology care offered by Dr. Morin.
- Are consultations and treatments with Dr. Morin, an Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Morin are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Morin's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Morin, an Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Morin for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- What is targeted therapy in cancer treatment?
- Targeted therapy uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. These therapies work by targeting specific genes or proteins found in cancer cells or cells related to cancer growth, like blood vessel cells. Genetic testing of the tumor is often done to see if a targeted therapy is likely to be effective. Dr. Morin can explain if targeted therapy is an option for your cancer.
- What happens after cancer treatment is completed with Dr. Morin?
- After active cancer treatment finishes, Dr. Morin will develop a survivorship care plan with you. This plan typically includes a schedule for follow-up appointments and tests to monitor for any signs of recurrence, management of any long-term side effects from treatment, recommendations for healthy lifestyle choices (diet, exercise), and coordination with your family doctor for ongoing general health care. The goal is to support your long-term health and well-being.
- What can I expect at my first appointment with an Oncologist/Hematologist?
- Your first appointment with Dr. Morin will be comprehensive and may last an hour or more. It will involve a detailed review of your medical history, family history of cancer, current symptoms, medications, and any previous tests, imaging results (CT, MRI, PET scans), and biopsy reports related to your diagnosis. He will likely perform a thorough physical examination. The main goals are to confirm your diagnosis, discuss the type and stage of your condition (if applicable), and outline potential treatment options. This is a crucial time to ask questions, and you are encouraged to bring a family member or friend for support and to help take notes. Dr. Morin will explain the proposed treatment plan, including goals, benefits, potential side effects, duration, and what to expect moving forward. Further tests may be ordered.
- What kind of supportive care is available during cancer or hematology treatment with Dr. Morin?
- Supportive care is a crucial part of treatment, aiming to manage symptoms, reduce side effects, improve quality of life, and address emotional and practical needs. This can include effective pain and symptom management, nutritional support and counseling, psychological support (counseling, therapy), social work services for practical and emotional support, physiotherapy or occupational therapy, access to patient support groups, and spiritual care. Dr. Morin and the healthcare team at affiliated hospitals or cancer centres can connect you with these valuable resources.
- Does Dr. Morin participate in or offer access to clinical trials?
- Many oncologists and hematologists are involved in clinical research to advance cancer treatment and care for blood disorders, as participation in clinical trials can offer access to new and investigational treatments. Dr. Morin is actively involved in clinical trials and may discuss relevant trial options with you if you are eligible and it is appropriate for your condition. You can ask Dr. Morin if there are any suitable clinical trials available for your condition, either at Dr. Morin's institution or through collaborative research networks. He can provide information or refer you for consideration.
- What are common side effects of chemotherapy, and how does Dr. Morin help manage them?
- Chemotherapy can cause various side effects, which differ depending on the specific drugs used, the dose, and individual patient factors. Common ones include fatigue, nausea, vomiting, hair loss, mouth sores, changes in appetite, diarrhea or constipation, and increased risk of infection due to low blood counts. Dr. Morin and the oncology nursing team will discuss potential side effects of your specific treatment plan in detail and will actively work to prevent and manage them with medications (e.g., anti-nausea drugs, growth factors to boost blood counts), supportive care advice (nutrition, hydration, rest), and regular monitoring. Open communication about any side effects you experience is very important for effective management.
CHU Sherbrooke
3001 12e Avenue N
Sherbrooke, QC J1H 5N4
Phone: (819) 346-1110 | Fax: (819) 564-5434
The facility is wheelchair accessible.
Dr. Morin is a licensed Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=16567